EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieVergleichsstudieOpen access

Virtual Reality–Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial

Mélissa Beaudoin iD, Stéphane Potvin iD, Sabrina Giguère iD, Charles-Édouard Giguère iD, Frederick Aardema iD, Amal Abdel-Baki, Luigi De Benedictis, Olivier Lipp iD, Pierre Lalonde iD, Emmanuel Stip iD, Alexandra Fortier iD, Kingsada Phraxayavong and 1 more

JMIR Mental Health · 2026-09-16 · 13 · e106791-e106791

DOI: 10.2196/106791 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Mental Health, published online on 2026-09-16. Written by Mélissa Beaudoin and 12 co-authors. Institution: Department of Psychiatry and Addictology, Université de Montréal, 2900, boul. Édouard-Montpetit, Montreal, QC, H3T 1J4, Canada, 1 514-251-4000 ext 39…. Major MEDLINE topics: Cognitive Behavioral Therapy, Hallucinations, Schizophrenia, Treatment-Resistant, Virtual Reality Exposure Therapy. 56 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Auditory verbal hallucinations (AVH) are among the most disabling symptoms of schizophrenia and often persist despite treatment. Virtual reality–assisted therapies (VRTs) are a new generation of relational interventions for AVH, but comparative evidence against active interventions is currently lacking.

Objective

This study aimed to assess whether VRT (9 sessions) is superior to a short course of cognitive behavioral therapy (CBT) targeting AVH (9 sessions) in reducing AVH in individuals with treatment-resistant schizophrenia.

Methods

In this assessor-blind, parallel-group randomized controlled trial conducted from 2019 to 2026 at an academic center in Montreal (Canada), adults with schizophrenia or schizoaffective disorder and persistent AVH were either referred by their health care team or self-referred. A total of 136 participants were randomly assigned 1:1 to VRT or CBT, stratified by sex and clozapine use status. Both 9-session interventions targeted maladaptive beliefs and relationships with voices and were administered by trained psychotherapists. The predetermined primary outcome was the evolution of AVH severity over time, measured at baseline, post treatment, and 3 months post therapy using the auditory hallucination subscale of the Psychotic Symptoms Rating Scale. Secondary outcomes notably included the general psychotic symptomatology measured using the Positive and Negative Syndrome Scale. Linear mixed-effects models were used to assess time-by-treatment interactions. Psychotherapy sessions and assessments were conducted primarily in person, with CBT being occasionally delivered via videoconferencing during the COVID-19 pandemic.

Results

Participants had a mean age of 40.3 (SD 12.8) years, 63.2% (86/136) were male, and 56.6% (77/136) received clozapine. Intention-to-treat analyses (VRT, n=67; CBT, n=69) showed a significant time-by-treatment interaction favoring VRT ( P =.013) with a moderate effect size at 3 months post therapy (Cohen d =0.614). Both therapies showed significant within-group improvements in the primary outcome, with large effect sizes for VRT (Cohen d =0.81 post therapy and Cohen d =1.17 at 3 months) and moderate for CBT (Cohen d =0.58 post therapy and Cohen d =0.39 at 3 months). While there were no between-group differences for secondary outcomes, within-group improvements were observed in psychotic symptoms, emotional regulation, and voice acceptance for both therapies, and VRT also reduced maladaptive beliefs about voices and improved self-esteem.

Conclusions

VRT outperformed a targeted short course of CBT in reducing persistent AVH for up to 3 months after the intervention in a North American population with treatment-resistant schizophrenia. Improvements were also seen in some secondary outcomes, such as general psychotic symptomatology, and those were similar for both interventions. Overall, these findings support the value of VRT as a personalized and clinically effective intervention.

Subjects

MeSH terms (MEDLINE)

Cognitive Behavioral TherapyHallucinationsSchizophrenia, Treatment-ResistantVirtual Reality Exposure TherapyHumansMaleFemaleAdultMiddle AgedTreatment OutcomePsychotic DisordersSingle-Blind Method

Author keywords

digital interventionspsychotherapiesrandomized controlled trialtreatment-resistant schizophreniavirtual reality–assisted psychotherapy

Authors and institutions

  • Department of Psychiatry and Addictology, Université de Montréal, 2900, boul. Édouard-Montpetit, Montreal, QC, H3T 1J4, Canada, 1 514-251-4000 ext 3925.
  • Institut universitaire en santé mentale de Montréal, Montreal, QC, Canada.
  • Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.

ORCID profiles: Mélissa Beaudoin, Stéphane Potvin, Sabrina Giguère, Charles-Édouard Giguère, Frederick Aardema, Olivier Lipp, Pierre Lalonde, Emmanuel Stip, Alexandra Fortier, Alexandre Dumais

Cite

APA

Beaudoin, M., Potvin, S., Giguère, S., Giguère, C. É., Aardema, F., Abdel-Baki, A., De Benedictis, L., Lipp, O., Lalonde, P., Stip, E., Fortier, A., Phraxayavong, K., & Dumais, A. (2026). Virtual Reality–Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial. JMIR Mental Health, 13, e106791-e106791. https://doi.org/10.2196/106791

Vancouver

Beaudoin M, Potvin S, Giguère S, Giguère CÉ, Aardema F, Abdel-Baki A, et al. Virtual Reality–Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial. JMIR Mental Health. 2026;13:e106791-e106791. doi:10.2196/106791

BibTeX
@article{Beaudoin2026,
  author = {Beaudoin, Mélissa and Potvin, Stéphane and Giguère, Sabrina and Giguère, Charles-Édouard and Aardema, Frederick and Abdel-Baki, Amal and De Benedictis, Luigi and Lipp, Olivier and Lalonde, Pierre and Stip, Emmanuel and Fortier, Alexandra and Phraxayavong, Kingsada and Dumais, Alexandre},
  title = {Virtual Reality–Assisted Therapy Compared to Cognitive Behavioral Therapy for Patients With Treatment-Resistant Schizophrenia: Assessor-Blind Randomized Controlled Trial},
  journal = {JMIR Mental Health},
  year = {2026},
  volume = {13},
  pages = {e106791--e106791},
  doi = {10.2196/106791}
}
Start for free →